| P50 | author | Paul A. Rota | Q88475153 |
| | Bettina Bankamp | Q88585610 |
| | Richard K Plemper | Q89312727 |
| | Jeong-Joong Yoon | Q90910396 |
| | Aiming Sun | Q108799219 |
| | James P. Snyder | Q115615654 |
| | Stefanie A Krumm | Q115615655 |
| | J Maina Ndungu | Q115615860 |
| P2093 | author name string | Vanessa Hoffman | |
| P2860 | cites work | Effect of single amino acid mutations in the conserved GDNQ motif of L protein of Rinderpest virus on RNA synthesis in vitro and in vivo | Q45696187 |
| | Analysis of the mutations in the active site of the RNA-dependent RNA polymerase of human parainfluenza virus type 3 (HPIV3). | Q45732155 |
| | An acidic activation-like domain of the Sendai virus P protein is required for RNA synthesis and encapsidation | Q45781270 |
| | Altered ratios of measles virus transcripts in diseased human brains | Q45830076 |
| | Two noncontiguous regions of sendai virus p protein combine to form a single nucleocapsid binding domain | Q45860018 |
| | Progress in global measles control and mortality reduction, 2000-2007. | Q50766310 |
| | The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection. | Q54123440 |
| | Measles eradication: is it in our future? | Q64130178 |
| | Expanded Programme on Immunization (EPI). Standardization of the nomenclature for describing the genetic characteristics of wild-type measles viruses | Q77324830 |
| | Update: measles--United States, January-July 2008 | Q81807920 |
| | Measles in Europe--there is room for improvement | Q83160964 |
| | Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity | Q24678611 |
| | In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase | Q28316126 |
| | Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture | Q28324214 |
| | A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors | Q28368028 |
| | Antiviral agents active against influenza A viruses. | Q30358429 |
| | Measles virus entry inhibitors: a structural proposal for mechanism of action and the development of resistance | Q30583105 |
| | Design of a small-molecule entry inhibitor with activity against primary measles virus strains | Q33222430 |
| | Polio--new challenges in 2006. | Q33242575 |
| | Developing new antiviral agents for influenza treatment: what does the future hold? | Q34015113 |
| | Measles elimination in the United States | Q34315972 |
| | Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay | Q34342086 |
| | Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications | Q34460359 |
| | Global measles elimination | Q34579842 |
| | Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex activity: Synthesis and in vitro evaluation | Q36178562 |
| | Rational design of polymerase inhibitors as antiviral drugs | Q36527113 |
| | Mapping of a region of the paramyxovirus L protein required for the formation of a stable complex with the viral phosphoprotein P. | Q36624116 |
| | Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present, and future | Q36693593 |
| | Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro | Q36700566 |
| | Potent non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex | Q36984136 |
| | Systems biology and the host response to viral infection | Q37027151 |
| | Molecular epidemiology of measles virus. | Q37388569 |
| | Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs | Q37391545 |
| | A target site for template-based design of measles virus entry inhibitors. | Q37682506 |
| | Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter | Q39548682 |
| | Measles virus spread by cell-cell contacts: uncoupling of contact-mediated receptor (CD46) downregulation from virus uptake | Q39594404 |
| | Dissection of individual functions of the Sendai virus phosphoprotein in transcription | Q39595235 |
| | Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor | Q39602523 |
| | The phosphoprotein (P) binding site resides in the N terminus of the L polymerase subunit of sendai virus | Q39682864 |
| | Strength of envelope protein interaction modulates cytopathicity of measles virus | Q39683453 |
| | Two N-terminal regions of the Sendai virus L RNA polymerase protein participate in oligomerization | Q40164787 |
| | The phosphoprotein (P) and L binding sites reside in the N-terminus of the L subunit of the measles virus RNA polymerase | Q40518655 |
| | Rescue of measles viruses from cloned DNA. | Q40790034 |
| | Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene | Q41349446 |
| | Host cell proteins required for measles virus reproduction | Q41738157 |
| | Reversible inhibition of the fusion activity of measles virus F protein by an engineered intersubunit disulfide bridge. | Q41775756 |
| | Two domains that control prefusion stability and transport competence of the measles virus fusion protein | Q41955046 |
| | The genomic termini of wild-type and vaccine strains of measles virus | Q45413719 |
| | Beta-catenin associates with human parainfluenza virus type 3 ribonucleoprotein complex and activates transcription of viral genome RNA in vitro | Q45626497 |
| | Rinderpest virus RNA polymerase subunits: mapping of mutual interacting domains on the large protein L and phosphoprotein p. | Q45674188 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | measles | Q79793 |
| P304 | page(s) | 3860-3870 | |
| P577 | publication date | 2009-06-15 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Target analysis of the experimental measles therapeutic AS-136A | |
| P478 | volume | 53 | |